Our results highlighted inhibition of PTGR2 as a new effective approach to prevent obesity, improve insulin sensitivity and insulin tolerance, and reduce hepatic steatosis without adverse side effects through increasing endogenous PPARγ ligands. Here, PPARG is linked to Obesity.